GSDMD and fatty liver disease: As expected, overexpression of NRF2 improved liver steatosis in diet‐induced obese mice, while inhibiting pyroptosis and inflammation markers, including cle‐Caspase1, GSDMD, N‐GSDMD, Pro‐IL1β and IL1β.